Vol.

No.

March 08, 2024Mar 08, 2024

DOWNLOAD THE PDF

Kathy Giusti’s “Fatal to Fearless” memoir tells the story of prevailing over multiple myeloma Book offers 12 steps to beating cancer in a broken medical system

Cover Story

Conversation with The Cancer Letter

Kathy Giusti’s “Fatal to Fearless” memoir tells the story of prevailing over multiple myeloma

Book offers 12 steps to beating cancer in a broken medical system

By Paul Goldberg

Sometimes in oncology, you get “beat-the-reaper” stories.

Free Obituary

Radiation oncologist, global health expert C. Norman Coleman dies of sarcoma at 79

By Paul Goldberg

News Analysis White House

Biden’s State of the Union highlights healthcare wins in cancer
White House announces ARPA-H precision cancer therapy program and patient navigation commitments

By Matthew Bin Han Ong

NCI, CRUK award $125M in Cancer Grand Challenge grants

By Jacquelyn Cobb

Cancer History Project Conversation with The Cancer Letter Free

Population scientist Monica Baskin is the “Jackie Robinson” of cancer center deputy directors

By Robert A. Winn, Paul Goldberg and Alexandria Carolan

Free In the Archives

Women’s History Month: Women who shaped oncology

In Brief

Diane Simeone begins work as director of Moores Cancer Center on April 1

Kenneth Griffin gifts $50M to Sylvester Comprehensive Cancer Center to help fund cancer research building

AACR publishes annual impact report

Rutgers Cancer Institute redesignated as NCI Comprehensive Cancer Center

Denene Prophet-Williams named vice president and chief nursing officer at Fred Hutchinson

Michael Egger, Christopher Manz, Serena Phillips receive 2023 Real-World Data Impact Award from ACS, Flatiron

Vittoria Bocchi, Julia Brunner, Melissa Yao, Tzippora Chwat-Edelstein named 2024 Kravis WiSE fellows

Twelve graduate students receive Fred Hutchinson 2024 Harold M. Weintraub Graduate Student Award

Medical College of Wisconsin constructing cancer research building

Clinical Roundup

Phase III Blenrep trial in multiple myeloma produces positive topline results

UCLA: Researchers uncover a potential genetic marker associated with better survival outcomes in head and neck cancer

UC researchers identify novel protein that may help prevent breast cancer spread

UC Davis study: TB vaccine shrinks liver cancer tumors in mice

Drugs & Targets

FDA approves Rybrevant for first-line treatment of EGFR-m NSCLC

FDA approves Opdivo + cisplatin + gemcitabine for unresectable or metastatic urothelial carcinoma

FDA grants accelerated approval to Brukinsa for R/R follicular lymphoma

FDA approves for first denosumab biosimilars

Elipses’s selective RET inhibitor EP0031/A400 granted Fast Track designation in NSCLC

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Kathy Giusti’s “Fatal to Fearless” memoir tells the story of prevailing over multiple myeloma

Radiation oncologist, global health expert C. Norman Coleman dies of sarcoma at 79

Biden’s State of the Union highlights healthcare wins in cancer
White House announces ARPA-H precision cancer therapy program and patient navigation commitments

NCI, CRUK award $125M in Cancer Grand Challenge grants

Population scientist Monica Baskin is the “Jackie Robinson” of cancer center deputy directors

Women’s History Month: Women who shaped oncology

In Brief

Diane Simeone begins work as director of Moores Cancer Center on April 1

Kenneth Griffin gifts $50M to Sylvester Comprehensive Cancer Center to help fund cancer research building

AACR publishes annual impact report

Rutgers Cancer Institute redesignated as NCI Comprehensive Cancer Center

Denene Prophet-Williams named vice president and chief nursing officer at Fred Hutchinson

Michael Egger, Christopher Manz, Serena Phillips receive 2023 Real-World Data Impact Award from ACS, Flatiron

Vittoria Bocchi, Julia Brunner, Melissa Yao, Tzippora Chwat-Edelstein named 2024 Kravis WiSE fellows

Twelve graduate students receive Fred Hutchinson 2024 Harold M. Weintraub Graduate Student Award

Medical College of Wisconsin constructing cancer research building

Clinical Roundup

Phase III Blenrep trial in multiple myeloma produces positive topline results

UCLA: Researchers uncover a potential genetic marker associated with better survival outcomes in head and neck cancer

UC researchers identify novel protein that may help prevent breast cancer spread

UC Davis study: TB vaccine shrinks liver cancer tumors in mice

Drugs & Targets

FDA approves Rybrevant for first-line treatment of EGFR-m NSCLC

FDA approves Opdivo + cisplatin + gemcitabine for unresectable or metastatic urothelial carcinoma

FDA grants accelerated approval to Brukinsa for R/R follicular lymphoma

FDA approves for first denosumab biosimilars

Elipses’s selective RET inhibitor EP0031/A400 granted Fast Track designation in NSCLC

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login